← Evidence map

ArticleTherapeutic advances in medical oncology2025

Efficacy and safety of rituximab biosimilar (DRL_RI) versus MabThera

Narendra Maharaj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
2026
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 40421128